Physician profile
Daniel L Shepherd
NPI 1164717518
$9,983.24
in general payments reported to CMS, 2019-2025
16 companies · $1,736 in 2025
The $1,736 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $512 · 2021: $200 · 2022: $5,090 · 2023: $1,675 · 2024: $659 · 2025: $1,736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,527 · Food and Beverage: $1,543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,526.88 |
| Food and Beverage | $1,543.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Camber Spine Technologies LLC | $5,116.95 | 2019-2023 | |
| Life Spine, INC. | $1,476.05 | 2025 | Trulift, Gruve Anterior Cervical Plate System, Prolift |
| Zimvie INC. | $1,385.03 | 2023 | |
| The Institute of Musculoskeletal Science and Education | $683.87 | 2020-2021 | |
| Highridge Medical LLC | $548.52 | 2024 | The Tether, Mobi-C Plug & Fit US, Spine-None |
| Biedermann Motech, INC. | $234.71 | 2023 | Moss100 Pedicle Screw System |
| Saluda Medical Americas, INC. | $177.64 | 2025 | Evoke |
| Zimmer Biomet Holdings, INC. | $90.70 | 2019 | |
| Boston Scientific Corporation | $86.76 | 2024 | |
| Stryker Corporation | $35.45 | 2022 | |
| Merck Sharp & Dohme LLC | $33.09 | 2025 | Reblozyl, Welireg |
| Zap Surgical Systems, INC. | $28.38 | 2020 | |
| Cerapedics INC. | $25.94 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Pacira Pharmaceuticals Incorporated | $23.91 | 2024 | Exparel, Zilretta, Iovera |
| Caris Mpi, INC. | $23.30 | 2025 | Mi Cancer Seek |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.94 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Shepherd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.